5F-AB-PINACA

5F-AB-PINACA

Legal status
Legal status	CA: Schedule II DE: Anlage II (Authorized trade only, not prescriptible) UK: Class B US: Schedule I Illegal in China and Singapore
Identifiers
IUPAC name N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-(5-fluoropentyl)indazole-3-carboxamide
CAS Number	1800101-60-3
PubChem CID	91936927
ChemSpider	29763723
UNII	3L83B2298V
CompTox Dashboard (EPA)	DTXSID401009970
Chemical and physical data
Formula	C18H25FN4O2
Molar mass	348.422 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC(C)[C@H](NC(=O)c1nn(CCCCCF)c2ccccc12)C(N)=O
InChI InChI=1S/C18H25FN4O2/c1-12(2)15(17(20)24)21-18(25)16-13-8-4-5-9-14(13)23(22-16)11-7-3-6-10-19/h4-5,8-9,12,15H,3,6-7,10-11H2,1-2H3,(H2,20,24)(H,21,25)/t15-/m0/s1 Key:WCBYXIBEPFZUBG-HNNXBMFYSA-N

5F-AB-PINACA is an indazole-based synthetic cannabinoid that is derived from a series of compounds originally developed by Pfizer in 2009 as an analgesic medication, and has been sold online as a designer drug.

5F-AB-PINACA has been reported to be a potent agonist of the CB₁ receptor and CB₂ receptor with EC₅₀ values of 0.48 nM and 2.6 nM respectively. Its metabolism has been described in literature.

Legality

China

As of October 2015 5F-AB-PINACA is a controlled substance in China.

Germany

5F-AB-PINACA is an Anlage II controlled substance in Germany as of May 2015.

Singapore

It is also controlled under the Fifth Schedule of the Misuse of Drugs Act (MDA) in Singapore as of May 2015.

See also